ロード中...
High-flow nasal oxygen therapy alone or with non-invasive ventilation in immunocompromised patients admitted to ICU for acute hypoxemic respiratory failure: the randomised multicentre controlled FLORALI-IM protocol
INTRODUCTION: Non-invasive ventilation (NIV) is recommended as first-line therapy in respiratory failure of critically ill immunocompromised patients as it can decrease intubation and mortality rates as compared with standard oxygen. However, its recommendation is only conditional. Indeed, the use o...
保存先:
| 出版年: | BMJ Open |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6701687/ https://ncbi.nlm.nih.gov/pubmed/31401603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-029798 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|